Cargando…

Usability of the Experience Sampling Method in Parkinson's Disease on a Group and Individual Level

BACKGROUND: Around 50% of PD patients experience motor fluctuations, which are often accompanied by mood fluctuations. The nature of the relationship between motor and mood fluctuations remains unknown. It is suggested that the experience sampling method can reveal such associations on both a group...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mulders, Anne E.P., van der Velden, Rachel M.J., Drukker, Marjan, Broen, Martijn P.G., Kuijf, Mark L., Leentjens, Albert F.G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2020
Materias:	Regular Issue Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496752/ https://www.ncbi.nlm.nih.gov/pubmed/32472594 http://dx.doi.org/10.1002/mds.28028

Ejemplares similares

Cognitive Behavioral Therapy for Anxiety in Parkinsonʼs Disease: A Randomized Controlled Trial
por: Moonen, Anja J.H., et al.
Publicado: (2021)

Unraveling the Relationship between Motor Symptoms, Affective States and Contextual Factors in Parkinson’s Disease: A Feasibility Study of the Experience Sampling Method
por: Broen, Martijn P. G., et al.
Publicado: (2016)

Neuroimaging of Anxiety in Parkinson's Disease: A Systematic Review
por: Carey, Guillaume, et al.
Publicado: (2020)

Cognitive Behavioral Therapy for Anxiety in Parkinson’s Disease Induces Functional Brain Changes
por: Carey, Guillaume, et al.
Publicado: (2023)

The ePark study protocol: A decentralized trial of individual video-assisted cognitive behavioural therapy for depressive disorder in Parkinson's disease
por: Erga, Aleksander H., et al.
Publicado: (2023)

Clinical Markers of Anxiety Subtypes in Parkinson Disease
por: Broen, Martinus P. G., et al.
Publicado: (2018)

Mobile Health Daily Life Monitoring for Parkinson Disease: Development and Validation of Ecological Momentary Assessments
por: Habets, Jeroen, et al.
Publicado: (2020)

Deep Brain Stimulation for Treatment-Resistant Depression: Towards a More Personalized Treatment Approach
por: Roet, Milaine, et al.
Publicado: (2020)

Corrigendum to “The ePark study protocol: A decentralized trial of individual video-assisted cognitive behavioural therapy for depressive disorder in Parkinson's disease” [Contemp. Clinic. Trials Commun. 32 (2023) 101080]
por: Erga, Aleksander H., et al.
Publicado: (2023)

Translating Evidence to Advanced Parkinson's Disease Patients: A Systematic Review and Meta‐Analysis
por: Nijhuis, Frouke A.P., et al.
Publicado: (2021)

Transcranial sonography findings related to depression in parkinsonian disorders: cross-sectional study in 126 patients
por: Bouwmans, Angela E.P., et al.
Publicado: (2016)

Stress and Mindfulness in Parkinson's Disease: Clinical Effects and Potential Underlying Mechanisms
por: van der Heide, Anouk, et al.
Publicado: (2020)

Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy‐Parkinsonism From Parkinson's Disease
por: Quattrone, Andrea, et al.
Publicado: (2022)

Measuring Parkinson's disease over time: The real‐world within‐subject reliability of the MDS‐UPDRS
por: Evers, Luc J.W., et al.
Publicado: (2019)

The Parkinson's Disease DNA Variant Browser
por: Kim, Jonggeol J., et al.
Publicado: (2021)

Estimating the Effect of Early Treatment Initiation in Parkinson's Disease Using Observational Data
por: van den Heuvel, Lieneke, et al.
Publicado: (2020)

Primary care nurses' perception of leadership and the influence of individual and work setting characteristics: A descriptive study
por: Brzozowski, Sarah L., et al.
Publicado: (2022)

Anxiety in Parkinson’s Disease Is Associated with Changes in Brain Structural Connectivity
por: Carey, Guillaume, et al.
Publicado: (2023)

Rapid culture‐independent loop‐mediated isothermal amplification detection of antimicrobial resistance markers from environmental water samples
por: Hassan, Marwa M., et al.
Publicado: (2023)

Altered Cholinergic Innervation in De Novo Parkinson's Disease with and Without Cognitive Impairment
por: van der Zee, Sygrid, et al.
Publicado: (2022)

Functional connectivity disruptions correlate with cognitive phenotypes in Parkinson's disease
por: Hassan, M., et al.
Publicado: (2017)

Diabetes and Neuroaxonal Damage in Parkinson's Disease
por: Vijiaratnam, Nirosen, et al.
Publicado: (2022)

Ventral Capsule/Ventral Striatum Stimulation in Obsessive‐Compulsive Disorder: Toward a Unified Connectomic Target for Deep Brain Stimulation?
por: van der Vlis, Tim A.M. Bouwens, et al.
Publicado: (2020)

State transitions and photosystems spatially resolved in individual cells of the cyanobacterium Synechococcus elongatus
por: Bhatti, Ahmad Farhan, et al.
Publicado: (2021)

Cerebrospinal Fluid Cytokines and Neurodegeneration‐Associated Proteins in Parkinson's Disease
por: Wijeyekoon, Ruwani S., et al.
Publicado: (2020)

Coding and Noncoding Variation in LRRK2 and Parkinson's Disease Risk
por: Lake, Julie, et al.
Publicado: (2021)

Apathy Induced by Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease: A Meta‐Analysis
por: Zoon, Thomas J.C., et al.
Publicado: (2020)

Accelerating Medicines Partnership: Parkinson's Disease. Genetic Resource
por: Iwaki, Hirotaka, et al.
Publicado: (2021)

Black and African American Connections to Parkinson's Disease Study: Addressing Missing Diversity in Parkinson's Disease Genetics
por: Bandres‐Ciga, Sara
Publicado: (2022)

The Role of Cholesterol in α‐Synuclein and Lewy Body Pathology in GBA1 Parkinson's Disease
por: García‐Sanz, Patricia, et al.
Publicado: (2020)

COVID‐19 Infection Enhances Susceptibility to Oxidative Stress–Induced Parkinsonism
por: Smeyne, Richard J., et al.
Publicado: (2022)

Gait‐Related Metabolic Covariance Networks at Rest in Parkinson's Disease
por: Sigurdsson, Hilmar P., et al.
Publicado: (2022)

Deterioration of Parkinson's disease during hospitalization: survey of 684 patients
por: Gerlach, Oliver HH, et al.
Publicado: (2012)

The Myelin‐Weighted Connectome in Parkinson's Disease
por: Boshkovski, Tommy, et al.
Publicado: (2021)

Levodopa Versus Dopamine Agonist after Subthalamic Stimulation in Parkinson's Disease
por: Picillo, Marina, et al.
Publicado: (2020)

Conversations With Dr. Oleh Hornykiewicz, Founding Father of the Dopamine Era in Parkinson's: How Do You Wish to Be Remembered?
por: Schlossmacher, Michael G., et al.
Publicado: (2020)

Allogeneic Bone Marrow–Derived Mesenchymal Stem Cell Safety in Idiopathic Parkinson's Disease
por: Schiess, Mya, et al.
Publicado: (2021)

The Parkinson's Disease Genome‐Wide Association Study Locus Browser
por: Grenn, Francis P., et al.
Publicado: (2020)

Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive Symptoms
por: Xie, Aoji, et al.
Publicado: (2022)

Neuromelanin, aging, and neuronal vulnerability in Parkinson's disease
por: Vila, Miquel
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8vb46a1rvpc83pojlfc1kbc5pb